Adherence to a Mediterranean diet, dyslipidemia and inflammation in familial hypercholesterolemia

Nutr Metab Cardiovasc Dis. 2021 Jun 30;31(7):2014-2022. doi: 10.1016/j.numecd.2021.04.006. Epub 2021 Apr 19.

Abstract

Background and aims: Familial Hypercholesterolemia (FH) is characterized by elevated LDL-cholesterol (LDL-C) and high atherosclerosis risk. The impact of different dietary patterns on atherosclerosis biomarkers has been poorly studied in FH. This study verified the association of adherence to a Mediterranean diet with biomarkers of dyslipidemia and low-grade inflammation in molecularly proven FH adults from Brazil (BR) and Spain (SP).

Methods and results: In this cross-sectional study adherence to the Mediterranean diet was assessed by a validated score and generalized estimating equations were used to evaluate its association with plasma LDL-C, apolipoprotein-B (ApoB) and high sensitivity C-reactive protein (hs-CRP) concentrations. We included 92 (mean age 45 years, 58.7% females) and 98 FH individuals (mean age 46.8 years, 60.2% females) respectively from BR and SP. FH causing variants did not differ between countries. LDL-C, ApoB and hs-CRP concentrations were higher in BR than in SP: 179 (135-250) and 161 (133-193) mg/dL; 141 (109-181) and 103 (88-134) mg/dL; and 1.6 (0.8-4.0) and 0.8 (0.4-1.5) mg/L respectively (all p < 0.001). Most of BR had low adherence (n = 77, 83.7%), while the majority of SP were divided into moderate (n = 35, 35.7%) and strong adherence to the Mediterranean diet (n = 37, 37.8%), p < 0.001. There was a significant inverse association of adherence to the Mediterranean diet score with higher LDL-C, ApoB, and hs-CRP after adjusting for socio economic parameters, caloric and fatty acid intakes as well as pharmacological lipid lowering therapies.

Conclusions: Higher adherence to a Mediterranean diet was associated with better dyslipidemia and low-grade inflammation profiles in FH.

Keywords: Cardiovascular diseases; Cholesterol; Familial hypercholesterolemia; Hyperliproteinemia type II; Inflammation; Mediterranean diet.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Biomarkers / blood
  • Brazil / epidemiology
  • Cardiovascular Diseases* / blood
  • Cardiovascular Diseases* / diagnosis
  • Cardiovascular Diseases* / epidemiology
  • Cardiovascular Diseases* / prevention & control
  • Cross-Sectional Studies
  • Diet, Healthy*
  • Diet, Mediterranean*
  • Feeding Behavior
  • Female
  • Heart Disease Risk Factors
  • Humans
  • Hyperlipoproteinemia Type II* / blood
  • Hyperlipoproteinemia Type II* / diagnosis
  • Hyperlipoproteinemia Type II* / diet therapy
  • Hyperlipoproteinemia Type II* / epidemiology
  • Inflammation Mediators* / blood
  • Inflammation* / blood
  • Inflammation* / diagnosis
  • Inflammation* / epidemiology
  • Inflammation* / prevention & control
  • Lipids* / blood
  • Male
  • Middle Aged
  • Nutritive Value
  • Patient Compliance*
  • Protective Factors
  • Risk Assessment
  • Risk Reduction Behavior*
  • Spain / epidemiology
  • Time Factors
  • Treatment Outcome

Substances

  • Biomarkers
  • Inflammation Mediators
  • Lipids